Skip to Main Content

Need health insurance? Shop our plans.

Need health insurance? Shop our plans.

News

Payment Policy Updates: Effective May 19, 2026

Date: 03/20/26

Ambetter Health of Delaware reviews all clinical policies at least annually. This review is done to ensure medical necessity review criteria is current and appropriate for members and the scope of the services. On a bi-monthly basis, prior to updates, clinical policies are reviewed and approved by the National Marketplace Quality Improvement Committee (QIC).

This page reflects all clinical and policy changes. The full list of policies are on the Clinical and Payment Policies section under Provider Resources.

Please reach out to your Provider Engagement Administrator if you have any questions.

Policy Updates: Effective: May 19th, 2026

CLINICAL POLICIES WITH CHANGES

  • Allogeneic Hemapoietic Cell Transplants for SCA and Beta Thalassemia CP.MP.108
  • Applied Behavior Analysis CP.MP.104
  • Applied Behavioral Analysis Documentation Requirements CP.BH.105
  • Bariatric Surgery CP.MP.37
  • Behavioral Health Clinical Policy Committee BH.CPC.01
  • Biofeedback CP.MP.168
  • Clinical Policy Web Posting CP.CPC.02
  • Concert Genetic Testing Oncology: Algorithmic Assays
  • Concert Genetic Testing Oncology: Cancer Screening and Surveillance V2.2025
  • Concert Genetic Testing Oncology: Hematologic Malignancy V2.2025
  • Concert Genetic Testing Oncology: Solid Tumor Molecular Diagnostics V2.2025
  • Concert Genetic Testing: Cardiovascular V2.2025
  • Concert Genetic Testing: Gastroenterology V2.2025
  • Concert Genetic Testing: Hereditary Cancer V2.2025
  • Concert Genetic Testing: Identity and Forensics V2.2025
  • Concert Genetic Testing: Multisystem Genetic Conditions V2.2025
  • Concert Genetic Testing: Nephrology V2.2025
  • Concert Genetic Testing: Neurology V2.2025
  • Concert Genetic Testing: Nutrition and Metabolism V2.2025
  • Concert Genetic Testing: Preimplantation Genetic Testing V2.2025
  • Concert Genetic Testing: Prenatal Screening V2.2025
  • Concert Genetic Testing: Toxicology and Pharmacogenetics Version A V2.2025
  • Concert Genetic Testing: Transplant V2.2025
  • Cosmetic and Reproductive Procedures CP.MP.31
  • DME CP.MP.107
  • Experimental Technologies CP.MP.36
  • Hyperhidrosis Treatments CP.MP.62
  • Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea CP.MP.180
  • IV Moderate and IV Deep Sedation and Gen Anesth for Dental Procedures CP.MP.61
  • Medical Necessity Criteria CP.CPC.05
  • Obstetrical Home Care Programs CP.MP.91
  • Orthognathic Surgery CP.MP.202
  • Outpatient Oxygen Use CP.MP.190
  • Panniculectomy CP.MP.109
  • Pediatric Heart Transplant CP.MP.138
  • Proton and Neutron Beam Therapies CP.MP.70
  • Radiation Therapy for Skin Cancer CP.MP.251
  • Selective Dorsal Rhizotomy for Spasticity in Cerebral Palsy CP.MP.174
  • Skin and Soft Tissue Substitutes for Diabetic Foot Ulcers and Venous Leg Ulcers CP.MP.185
  • Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation CP.MP.117
  • State Specific Clinical Policy Process CP.CPC.04

NEW CLINICAL POLICIES

  • Concert Genetic Testing: Identify and Forensics V2.2025
  • Concert and Genetic Testing: Nutrition and Metabolism V2.2025